BNP Paribas Financial Markets’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,832
Closed -$475K 5556
2025
Q2
$475K Sell
4,832
-377
-7% -$35.7K ﹤0.01% 3357
2025
Q1
$483K Sell
5,209
-1,301
-20% -$120K ﹤0.01% 3203
2024
Q4
$591K Sell
6,510
-660
-9% -$60.6K ﹤0.01% 3179
2024
Q3
$692K Sell
7,170
-778
-10% -$75.9K ﹤0.01% 2699
2024
Q2
$730K Sell
7,948
-4,102
-34% -$381K ﹤0.01% 2458
2024
Q1
$1.11M Buy
12,050
+6,358
+112% +$596K ﹤0.01% 2427
2023
Q4
$541K Buy
5,692
+2,421
+74% +$226K ﹤0.01% 2744
2023
Q3
$306K Sell
3,271
-674
-17% -$62.3K ﹤0.01% 2951
2023
Q2
$361K Sell
3,945
-2,578
-40% -$211K ﹤0.01% 2748
2023
Q1
$480K Sell
6,523
-35,499
-84% -$3.07M ﹤0.01% 2761
2022
Q4
$3.51M Buy
42,022
+7,225
+21% +$651K 0.01% 1491
2022
Q3
$3.37M Sell
34,797
-79,000
-69% -$9.42M 0.01% 1583
2022
Q2
$12M Buy
113,797
+96,587
+561% +$12.3M 0.02% 819
2022
Q1
$2.97M Sell
17,210
-42,203
-71% -$6.31M ﹤0.01% 1581
2021
Q4
$9.62M Buy
59,413
+48,734
+456% +$7.83M 0.01% 978
2021
Q3
$1.59M Buy
10,679
+1,296
+14% +$269K ﹤0.01% 2055
2021
Q2
$2.3M Sell
9,383
-2,567
-21% -$674K ﹤0.01% 1692
2021
Q1
$3.16M Buy
11,950
+2,492
+26% +$703K ﹤0.01% 1432
2020
Q4
$2.77M Sell
9,458
-645
-6% -$165K 0.01% 1450
2020
Q3
$2.39M Sell
10,103
-2,535
-20% -$576K ﹤0.01% 1430
2020
Q2
$2.51M Sell
12,638
-6,872
-35% -$1.28M ﹤0.01% 1395
2020
Q1
$3.58M Buy
19,510
+10,458
+116% +$1.86M 0.01% 1150
2019
Q4
$1.51M Buy
9,052
+1,675
+23% +$249K ﹤0.01% 1823
2019
Q3
$966K Buy
7,377
+2,250
+44% +$293K ﹤0.01% 1866
2019
Q2
$622K Sell
5,127
-2,481
-33% -$294K ﹤0.01% 1906
2019
Q1
$938K Buy
7,608
+3,311
+77% +$416K ﹤0.01% 1731
2018
Q4
$503K Buy
4,297
+2,238
+109% +$264K ﹤0.01% 1803
2018
Q3
$257K Sell
2,059
-2,875
-58% -$317K ﹤0.01% 2299
2018
Q2
$422K Sell
4,934
-4,755
-49% -$349K ﹤0.01% 2081
2018
Q1
$585K Sell
9,689
-2,565
-21% -$146K ﹤0.01% 2105
2017
Q4
$646K Sell
12,254
-3,993
-25% -$210K ﹤0.01% 2297
2017
Q3
$909K Buy
16,247
+4,682
+40% +$248K ﹤0.01% 1620
2017
Q2
$726K Buy
11,565
+4,475
+63% +$261K ﹤0.01% 1703
2017
Q1
$362K Sell
7,090
-2,076
-23% -$99K ﹤0.01% 1908
2016
Q4
$391K Buy
9,166
+2,110
+30% +$89.7K ﹤0.01% 1816
2016
Q3
$335K Sell
7,056
-3,909
-36% -$195K ﹤0.01% 1456
2016
Q2
$554K Buy
10,965
+3,966
+57% +$200K ﹤0.01% 1466
2016
Q1
$338K Sell
6,999
-6,501
-48% -$251K ﹤0.01% 1320
2015
Q4
$531K Buy
13,500
+5,572
+70% +$223K ﹤0.01% 1338
2015
Q3
$301K Sell
7,928
-178
-2% -$7.51K ﹤0.01% 1690
2015
Q2
$322K Sell
8,106
-1,235
-13% -$38.5K ﹤0.01% 1509
2015
Q1
$250K Sell
9,341
-12,020
-56% -$339K ﹤0.01% 1502
2014
Q4
$627K Sell
21,361
-26,244
-55% -$648K ﹤0.01% 1068
2014
Q3
$960K Sell
47,605
-173
-0.4% -$3.34K ﹤0.01% 1263
2014
Q2
$800K Buy
47,778
+8,954
+23% +$127K ﹤0.01% 1287
2014
Q1
$529K Buy
38,824
+34,008
+706% +$523K ﹤0.01% 1407
2013
Q4
$70.5K Buy
+4,816
New +$77.5K ﹤0.01% 1787
2013
Q3
Sell
-10,590
Closed -$123K 2568
2013
Q2
$123K Buy
+10,590
New +$121K ﹤0.01% 2490

Other funds holding AMED

BNP Paribas Financial Markets's AMED Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,832 shares — an estimated $475K sold.

BNP Paribas Financial Markets first reported a position in AMED in Q2 2013 and held it in 48 quarters. The position peaked at $12M in Q2 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 4,832 Amedisys shares in Q3 2025, an estimated $475K.
  • BNP Paribas Financial Markets first reported a position in Amedisys in Q2 2013 and held it in 48 quarters.
  • BNP Paribas Financial Markets's Amedisys position peaked at $12M in Q2 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.